FMP
Protagenic Therapeutics, Inc.
PTIX
NASDAQ
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
0.439 USD
-0.0091 (-2.07%)
We are unable to load the chart at this time.
Date
Revenue
Earnings
Estimated Earnings
Surprise
2024-11-14
25.14k
-0.14
0
-
2024-08-14
0
-0.36
0
-
2024-04-01
0
-0.38
0
-
2024-03-26
3.2k
-0.38
0
-
2023-11-14
0
-0.32
0
-
2023-08-14
0
-0.28
0
-
2023-05-15
0
-0.17
0
-
2023-04-17
0
0.05
0.09
-44.44%
2022-11-14
0
-0.2
0
-
2022-08-11
0
-0.16
0
-
2022-05-13
0
-0.32
0
-
2022-04-07
-480.51k
-0.2
-0.09
122.22%
2021-11-16
0
-0.2
-0.08
150.00%
2021-08-16
0
-0.44
0
-
2021-05-17
0
-0.44
0
-
2021-03-25
0
-0.2
0
-
2020-11-16
0
-0.4
0
-
2020-08-14
0
-0.24
0
-
2020-06-18
0
-0.2
0
-
2020-04-29
0
-0.28
0
-
2019-11-14
0
-0.04
0
-
2019-08-14
0
-0.2
0
-
2019-05-15
0
-0.24
0
-
2019-05-15
0
-0.23
0
-
2018-11-08
0
-0.2
0
-
2018-08-14
0
-0.28
0
-
2018-05-15
0
-0.24
0
-
2018-04-02
0
-0.27
0
-
2017-11-13
0
-0.16
0
-
2017-08-08
0
-0.16
0
-
2017-05-15
0
-0.26
0
-
2017-04-17
0
-0.28
0
-
2016-11-17
0
-0.24
0
-
2016-08-15
0
-59.72
0
-
2016-07-25
0
-211.49
0
-
2016-03-11
0
-24.31
0
-
2015-11-13
0
-20.15
0
-
2015-09-25
0
-17.23
0
-
2015-05-11
0
-18.31
0
-
2015-02-06
0
-20.46
0
-
2014-11-13
0
-17.23
0
-
2014-10-14
0
-14.77
0
-
2014-03-31
0
-56.92
0
-
2013-12-31
0
-33.85
0
-
2013-09-30
0
-60.62
0
-
2011-11-14
12.33M
-43.9k
0
-
2011-08-15
6.27M
-60.32k
0
-
2011-05-16
7.05M
-31.1k
0
-
2011-04-07
7.84M
-96.06k
0
-
2010-11-15
9.18M
-43.29k
0
-
2010-08-16
10.81M
-53.48k
0
-
2010-05-11
12.2M
-40.89k
0
-
2010-03-30
13.66M
-281.76k
0
-